In the calculation of risks associated with basic clinical features, it can be found that in TCGA‐GBM, there are statistically significant differences based on age, IDH mutation, and 1p19q codeletion status (Table 1; Figure S1A). The gene discussed is IDH1; the disease is glioblastoma.